You can buy or sell GALT and other stocks, options, ETFs, and crypto commission-free!
Galectin Therapeutics Inc. Common Stock, also called Galectin Therapeutics, is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Read More Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
52 Week High
52 Week Low
Research And Development
Expected May 9, Pre-Market